Records containing: Hepatitis C, Chronic
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Long-Term Follow-Up Of Subjects With CHC Who Achieved A Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
-
CLINICAL_TRIALS study record update · 2026-04-24A Prospective, Interventional, Longitudinal Asia Pacific Study Evaluating Clinical Utility of Des-gamma-carboxyprothrombin (PIVKA-II) or GAAD Score Plus Ultrasound for Detection of Hepatocellular Carcinoma (HCC) in a High-risk Patient Population
-
CLINICAL_TRIALS study record update · 2026-04-15Safety, Tolerability, and Outcomes of Velpatasvir/SofosbuviR in Treatment of Chronic Hepatitis C Virus During Pregnancy (STORC)
-
CLINICAL_TRIALS study record update · 2026-04-13Study of the Effects of a Sartan on Hepatic Fibrosis Progression in Chronic Viral Hepatitis C
-
CLINICAL_TRIALS study record update · 2026-04-13An Evaluation of Bemnifosbuvir-Ruzasvir (BEM/RZR) Versus Sofosbuvir-Velpatasvir (SOF/VEL) for the Treatment of Chronic Hepatitis C Virus (HCV) Infection in a Phase 3 Randomized, Controlled, Open-label Study
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-13Impact of Interferon Free Regimens in Patients With Chronic HCV and Successfully Treated HCC
-
CLINICAL_TRIALS study record update · 2026-04-02Pilot Study of PegInterferon-Ribavirin-Telaprevir Efficacy and Tolerability in HIV-HCV Coinfected Patients Who Had Previously Failed a PegInterferon-Ribavirin Regimen. (ANRS HC26 TelapreVIH)
-
CLINICAL_TRIALS study record update · 2025-10-21A Phase 2, Open-label Study to Assess the Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic Hepatitis C Virus (HCV) Infection
-
CLINICAL_TRIALS study record update · 2025-09-16Integrated Treatment of Hepatitis C Virus Infection Among Patients With Injecting Drug Abuse:a Randomised Controlled Trial (INTRO-HCV)
-
CLINICAL_TRIALS study record update · 2025-07-17A Multi-centre, Practice-level, Cluster Randomized Controlled Trial to Compare Point-of-care HCV RNA Testing, Dried Blood Spot Testing, and Standard of Care to Enhance Treatment Uptake Among People With HCV Who Have Recently Injected Drugs Attending Needle and Syringe Programs: the TEMPO Study
-
CLINICAL_TRIALS study record update · 2025-05-28The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study
-
CLINICAL_TRIALS study record update · 2025-03-24Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs
-
CLINICAL_TRIALS study record update · 2025-03-04Implementation of Low Cost Solutions to Help Facilitate Linkage to Care for Persons with Hepatitis C Virus Infection
-
CLINICAL_TRIALS study record update · 2025-01-01Phase 1 Pharmacokinetic Trial of Sofosbuvir/Velpatasvir in Pregnant Women With Chronic Hepatitis C Virus Infection
-
CLINICAL_TRIALS study record update · 2024-01-25Rapid HCV RNA Testing and LInkage to Care
-
CLINICAL_TRIALS study record update · 2023-08-22Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy
-
CLINICAL_TRIALS study record update · 2023-08-14A Monocenter Randomized Double-blind Placebo-controlled Study to Investigate Neuropsychiatric Manifestations of HCV-infection During and After Treatment With Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir
-
CLINICAL_TRIALS study record update · 2023-07-27A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ORAL PF-04136309 500 MG BID IN SUBJECTS WITH CHRONIC HCV INFECTION AND RAISED AMINOTRANSFERASES
-
CLINICAL_TRIALS study record update · 2023-07-06Evaluation of Prolonged-release Pirfenidone in Patients With Viral C Hepatitis, With Sustained Viral Response and Advanced Residual Liver Fibrosis. Potential Role of Epigenetics to Understand Therapeutic Changes (MINERVA).
-
CLINICAL_TRIALS study record update · 2023-05-23Exploration of A Holistic Management Procedure for Liver Cancer Surveillance in Improving Liver Cancer's Early Diagnosis Efficacy in Chinese Population: Single-Center, Prospective, Observational Real-world Study in EASTERN China
-
CLINICAL_TRIALS study record update · 2023-05-06Localized on -Site Testing and Treatment of Hepatitis C in Homeless Persons in South London: a Pilot Non-randomised Phase 4 Interventional Clinical Trial of Grazoprevir and Elbasvir ± Ribavirin in Participants With Genotype 1a, 1b or 4 to Measure Efficacy and Adherence to Treatment in a Homeless Population
-
CLINICAL_TRIALS study record update · 2023-05-06Using the Cepheid GeneXpert HCV VL Fingerstick Test as a Diagnostic Tool for Chronic Hepatitis C Among Drug Users in Brussels
-
CLINICAL_TRIALS study record update · 2023-05-06Management of Hepatitis C Virus (HCV) Infection in Pregnant Women With Opioid Use Disorder (OUD): the Potential of an Integrated Medical Home Model: Phase IV Trial of Sofosbuvir/Velpatasvir (SOF/VEL) in Postpartum Women With Chronic HCV
-
CLINICAL_TRIALS study record update · 2023-04-14Epidemiology of Occult Hepatitis C Virus Infection in Patients Born Before 1969 in the Hospital Setting: a Spontaneous Opportunistic Screening Initiative.
-
CLINICAL_TRIALS study record update · 2022-12-05ClinicalTrials.gov study NCT00062816